The cardiovascular care of thousands of Missouri patients is suddenly up in the air. The heart of the issue is a practice's alleged interest in opening up a new private equity-backed clinic.
On Tuesday, a judge formally rejected a motion by the company to have the case dismissed. Carelon Behavioral Health, a subsidiary of Elevance, is accused of publishing an inaccurate directory of providers for those seeking mental health services.
Purdue Pharma, a drug manufacturer and maker of the popular opioid OxyContin, filed for bankruptcy in the fallout of thousands of lawsuits targeting the company for its role in the national opioid abuse and overdose epidemic.
Emerging technologies like AI and robotics have vast potential to improve healthcare. Few question this. What remains unclear is how meaningful the advances will be to healthcare providers and, more to the point, the patients they serve.
Civica Rx, a not-for-profit drug company with $100 million in funding that aims to combat drug shortages, has inked its next deal with Exela Pharma Sciences to supply its membership of hospitals with sodium bicarbonate injections.
Fresh off the heels of its announcement to enter primary care with its own clinic, retail giant Walmart is preparing a big push into the healthcare space.
